2-Thiazolamine, 4-[4-(phenylmethyl)phenyl]-

Catalog No. :
ACHGFR539
CAS No. :
68729-05-5
Molecular Formula :
C16H14N2S
Molecular Weight :
266.37

IUPAC Name:4-(4-benzylphenyl)thiazol-2-amine

2-Thiazolamine, 4-[4-(phenylmethyl)phenyl]- structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
10mg98%$54.00Login to see priceIn stockInquiry
25mg98%$80.00Login to see priceIn stockInquiry
50mg98%$117.00Login to see priceIn stockInquiry
100mg98%$141.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2-Thiazolamine, 4-[4-(phenylmethyl)phenyl]-
IUPAC Name4-(4-benzylphenyl)thiazol-2-amine
Molecular FormulaC16H14N2S
Molecular Weight266.37
SMILESNC1=NC(C2=CC=C(CC3=CC=CC=C3)C=C2)=CS1
InChI KeyXYDVHKCVOMGRSY-UHFFFAOYSA-N
SynonymARM1;4-(4-Benzylphenyl)-1,3-thiazol-2-amine;ARM-1 (ARM1);2-Thiazolamine, 4-[4-(phenylmethyl)phenyl]-;Epoxide Hydrolase,ARM1,HCT-116 cells,Inhibitor,LTA4H,ARM-1,cytotoxic,positive control,Aminopeptidase,4BSA,inhibit,ARM 1;2-Thiazolamine, 4-[4-(phenylmethyl)phenyl]- , ARM1;ARM1, 10 mM in DMSO
CAS No.68729-05-5
PubChem CID3768902

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319
Precautionary Statement(s)
P264-P270-P280-P301+P312+P330-P302+P352-P305+P351+P338-P332+P313-P337+P313-P362+P364-P501

Synthetic Route by SureRoute

1. ACHGFR539 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACHGFR539 route product structure diagram
    ACHGFR53968729-05-5 In Stock
Inquiry

2. ACHGFR539 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACHGFR539 route product structure diagram
    ACHGFR53968729-05-5 In Stock
Inquiry

Comments (0)